홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Methotrexate → HCID 178432404, 화합물

HRID 905098
인쇄

반응식

HRID 905098 반응식
CN(C1C=[CH:18][C:19]([C:22](N[C@H](C(O)=O)CCC(O)=O)=[O:23])=CC=1)CC1C=NC2N=C(N)N=C(N)C=2N=1.Cl.[NH2:35][C:36]1[N:41]=[C:40]([NH2:42])[N:39]=[C:38]([NH2:43])[C:37]=1[NH2:44].OC(O)C(=O)C>O>[NH2:42][C:40]1[N:41]=[C:36]([NH2:35])[C:37]2[C:38](=[N:43][C:19]([CH3:18])=[C:22]([OH:23])[N:44]=2)[N:39]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 126941MethotrexateHCID 131809821,1-Dihydroxypropan-2-oneHCID 204773462,4,5,6-Tetraaminopyrimidine hydrochloride

생성물 1

HCID 178432404HCID 178432404, 화합물

시약·촉매·용매 1

HCID 962Water용매

실험 절차

The well-known Ellard process is exemplified by U.S. Pat. No. 4,080,325 Ellard and claim 1 of the patent sets out the steps for preparing methotrexate as follows: (a) reacting tetraaminopyrimidinehydrochloride with dihydroxyacetone in the presence of air and water and at a pH in the range of 5.5±0.2 to give 2,4-diamino-6-hydroxy-methylpteridine; (b) converting the 2,4-diamino-6-hydroxy-methylpteridine to the hydrobromide salt, namely, 2,4-diamino-6-hydroxymethylpteridine hydrobromide salt; (c) reacting the 2,4-diamino-6-hydroxymethylpteridine hydrobromide salt with triphenyldibromophosphorane to give 2,4-bis(triphenylphosphazine)-6-bromomethylpteridine hydrobromide; (d) reacting the 2,4-bis(triphenylphosphazino)-6-bromomethylpteridine hydrobromide with ethyl N-(p-methylamino)benzylglutamate to give the phosphazino derivative of methotrexate ester; (e) hydrolyzing the phosphazino derivative of methotrexate ester to give triphenylphosphine oxide and methotrexate ester; and (f) hydrolyzing the methotrexate ester to give methotrexate.

출처 및 근거

ORD 기록
ord-a2a198a517b241ec97f299a38a94d584
출처 데이터셋
uspto-grants-1983_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04421913

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트